http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101456754-B1

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-343
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-635
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0095
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4965
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-343
filingDate 2012-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2014-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2014-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-101456754-B1
titleOfInvention Parmaceutical Composition for Preventing or Treating Cancer Containing ABT-737 and Cafestol
abstract The present invention relates to a pharmaceutical composition for the prevention or treatment of cancer comprising ABT-737 and cafestol as an active ingredient. In the case of using ABT-737 and cafestol in combination, cancer cell-specific cell death And exhibits excellent anticancer activity in cancer cells overexpressing Mcl-1. Therefore, it can be usefully used for the prophylaxis or treatment of cancer, particularly, renal cancer.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20230051845-A
priorityDate 2012-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20120117810-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24445
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID221067
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449915478
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453947315
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419504195
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID104981
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453197090
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426174123
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439215
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11228183
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546112
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68772216
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10018664
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419524198

Total number of triples: 37.